A new report published in the Journal of Clinical Oncology provides new U.S. estimates of genetic testing in women with a history of breast or ovarian cancer. According to cross-sectional data from three Cancer Control Modules, "up to 10% of breast and 15% of ovarian cancers are attributable to hereditable mutations." This report thus quantifies the unmet need for genetic testing in patients with a history of breast and/or ovarian cancer.
To read this report in its entirety, click here.
Source mentioned: Childers CP, Childers KK, Maggard-Gibbons M, Macinko J. National estimates of genetic testing in women with a history of breast or ovarian cancer. J Clin Oncol. 2017 Aug 18:JCO2017736314. [Epub ahead of print]
No comments:
Post a Comment